As an approach to sensitize glioblastoma cells to TRAIL-induced cell death, lanatoside C has been shown to upregulate expression of TRAIL-R2 as well as to activate a necrosis-like and caspase-independent cell death pathway. Here, TNFSF10 is linked to glioblastoma.